August 04, 2016
HCA Midwest Health—Kansas City’s leading healthcare provider and a leader in cancer care—announced today that Ryan Hallenbeck, MBA, has been appointed Regional Vice President, Oncology Services for Sarah Cannon Cancer Institute at HCA Midwest Health.
In his new role, Hallenbeck is responsible for the operational development and coordination of oncology services throughout the Sarah Cannon Cancer Institute at HCA Midwest Health network and will help to enhance existing programs and work daily with Sarah Cannon and hospital medical directors to ensure quality, accessibility and accountability.
Since 2014, Hallenbeck has served as administrative director of Cancer Services at Research Medical Center, part of HCA Midwest Health, where he had strategic oversight for four outpatient clinics and medical oncology services, including chemotherapy, radiation oncology, gynecologic oncology and Gamma Knife radiosurgery. In addition, Hallenbeck directed the opening of the renovated gynecologic oncology clinic; collaborated with outreach clinics to grow volume and improve quality; and increased employee engagement and patient satisfaction.
Prior to joining HCA Midwest Health, Hallenbeck served as director of radiology at Shawnee Mission Medical Center where he led a group of more than 120 technologists, nurses and support staff and provided project leadership. Previously Hallenbeck served at University of Kansas Cancer Center where he managed new strategic projects for academic and community cancer services; collaborated with hospital leadership on project design and implementation; and was project lead on a CT lung screening program.
“Ryan’s depth of experience, proven leadership success and strength in building and managing collaborative relationships with physicians, clinical and administrative staff, support staff and vendors will help continue to elevate and position Sarah Cannon Cancer Institute at HCA Midwest Health as the market leader in cancer services and research,” says HCA Midwest Health President M.L. Lagarde III.
Hallenbeck holds a master’s degree in business administration from the University of Kansas; a certificate of completion from the University of Iowa Nuclear Medicine Technology program in Iowa City, Iowa; and a bachelor’s degree in athletic training from the University of Northern Iowa in Cedar Falls.
“Ryan’s seasoned experience in oncology will help us to further develop HCA Midwest Health’s comprehensive cancer care network together with Sarah Cannon’s strong foundation to ensure quality and accessibility for patients and their families,” said Fred LeMaistre, MD, Senior Vice President, Sarah Cannon Market Operations and Physician in Chief of Blood Cancers at Sarah Cannon in Nashville, Tennessee.
“I look forward to working in my new position to assure that HCA Midwest Health hospitals and patients receive the best cancer services available,” Hallenbeck says. “Sarah Cannon Cancer Institute at HCA Midwest Health provides the region with convenient, unprecedented access to our uniquely compassionate, patient-centered care model—a strategic initiative to not only invest in the community’s well-being, but to ensure high-quality cancer care is available to patients and their families, close to home.”
For more information on HCA Midwest Health and Sarah Cannon Cancer Institute at HCA Midwest Health, visit hcamidwest.com.